Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-19 4:05 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Carlson Capital L.P. | 124,000 3.450% | -93,960 (-43.11%) | View |
| 2024-11-14 3:37 pm Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | ARMISTICE CAPITAL LLC | 359,382 9.990% | 359,382 (New Position) | View |
| 2024-05-08 5:13 pm Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | INTRACOASTAL CAPITAL LLC | 155,589 4.990% | 155,589 (New Position) | View |
| 2024-05-08 4:26 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Carlson Capital L.P. | 217,960 9.120% | -1,624,040 (-88.17%) | View |
| 2024-02-14 6:48 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | LYTTON LAURENCE W | 11,900 0.100% | -3,113,822 (-99.62%) | View |
| 2023-02-14 3:32 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Lung Therapeutics Inc. | 773,000 2.100% | -1,462,000 (-65.41%) | View |
| 2023-02-13 4:03 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | LYTTON LAURENCE W | 3,125,722 8.400% | -11,919 (-0.38%) | View |
| 2023-02-09 4:30 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Carlson Capital L.P. | 1,842,000 5.100% | -352,000 (-16.04%) | View |
| 2022-11-28 4:17 pm Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | Carlson Capital L.P. | 2,194,000 6.200% | 2,194,000 (New Position) | View |
| 2022-11-23 1:01 pm Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | LYTTON LAURENCE W | 3,137,641 8.800% | 3,137,641 (New Position) | View |
| 2022-02-14 4:10 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Corriente Advisors LLC | 0 0.000% | -1,350,000 (Position Closed) | View |
| 2022-02-14 3:07 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Lung Therapeutics Inc. | 2,235,000 8.810% | -715,000 (-24.24%) | View |
| 2022-02-14 08:24 am Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Nantahala Capital Management LLC | 0 0.000% | -1,763,476 (Position Closed) | View |
| 2021-02-16 06:33 am Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | Corriente Advisors LLC | 1,350,000 6.070% | 1,350,000 (New Position) | View |
| 2021-02-16 06:25 am Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | Nantahala Capital Management LLC | 1,763,476 7.900% | 1,763,476 (New Position) | View |
| 2021-02-03 3:10 pm Sale | 13G | TFF PHARMACEUTICALS INC NE TFFP | Lung Therapeutics Inc. | 2,950,000 13.300% | -1,050,000 (-26.25%) | View |
| 2020-02-03 12:42 pm Purchase | 13G | TFF PHARMACEUTICALS INC NE TFFP | Lung Therapeutics Inc. | 4,000,000 21.700% | 4,000,000 (New Position) | View |